{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:18:11Z","timestamp":1780456691881,"version":"3.54.1"},"reference-count":14,"publisher":"Lavoisier","issue":"4","license":[{"start":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T00:00:00Z","timestamp":1297987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bull. Soc. Pathol. Exot."],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s13149-011-0135-7","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T16:17:48Z","timestamp":1298045868000},"page":"260-265","source":"Crossref","is-referenced-by-count":25,"title":["Persistance \u00e0 long terme des anticorps neutralisants de la fi\u00e8vre jaune chez les personnes \u00e2g\u00e9es de 60 ans et plus","Long term persistance of yellow fever neutralising antibodies in elderly persons"],"prefix":"10.3166","volume":"104","author":[{"given":"H.","family":"Coulange Bodilis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Benabdelmoumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gergely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Goujon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pelicot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Poujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. H.","family":"Consigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1762","published-online":{"date-parts":[[2011,2,18]]},"reference":[{"issue":"4","key":"135_CR1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4161\/hv.4.4.5751","volume":"4","author":"I.J. Amanna","year":"2008","unstructured":"Amanna IJ, Messaoudi I, Slifka MK (2008) Protective immunity following vaccination: how is it defined? Hum Vaccin 4(4): 316\u2013319. Epub 2008 Feb 19","journal-title":"Hum Vaccin"},{"issue":"5","key":"135_CR2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1586\/14760584.7.5.579","volume":"7","author":"E.D. Barnett","year":"2008","unstructured":"Barnett ED, Wilder-Smith A, Wilson ME (2008) Yellow fever vaccines and international travelers. Expert Rev Vaccines 7(5):579\u2013587","journal-title":"Expert Rev Vaccines"},{"key":"135_CR3","volume-title":"Immunog\u00e9nicit\u00e9 \u00e0 long terme de la vaccination contre la fi\u00e8vre jaune chez des voyageurs transplant\u00e9s d\u2019organe solide. Abstract J-08","author":"P.H. Consigny","year":"2009","unstructured":"Consigny PH, Mamzer MF, Bodilis H, Poujol P (2009) Immunog\u00e9nicit\u00e9 \u00e0 long terme de la vaccination contre la fi\u00e8vre jaune chez des voyageurs transplant\u00e9s d\u2019organe solide. Abstract J-08, 10es Journ\u00e9es nationales d\u2019infectiologie, Lyon"},{"issue":"15","key":"135_CR4","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.vaccine.2005.12.055","volume":"24","author":"M.J. Hepburn","year":"2006","unstructured":"Hepburn MJ, Kortepeter MG, Pittman PR, et al (2006) Neutralizing antibody response to booster vaccination with 17D yellow fever vaccine. Vaccine 24(15):2843\u20132849. Epub 2006 Jan 18","journal-title":"Vaccine"},{"issue":"25","key":"135_CR5","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","volume":"23","author":"A.Y. Khromava","year":"2005","unstructured":"Khromava AY, Eidex RB, Weld LH et al (2005) Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine 23(25):3256\u20133263","journal-title":"Vaccine"},{"issue":"10","key":"135_CR6","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/340104","volume":"34","author":"T.P. Monath","year":"2002","unstructured":"Monath TP, Cetron MS (2002) Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 34(10):1369\u20131378. Epub 2002 Apr 2","journal-title":"Clin Infect Dis"},{"issue":"5","key":"135_CR7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","volume":"66","author":"T.P. Monath","year":"2002","unstructured":"Monath TP, Nichols R, Archambault WT et al (2002) Comparative safety and immunogenicity of two yellow fever 17D vaccines (Arilvax? and YF-VAX) in a phase III multicenter, double-blind clinical trial. Am J Trop Med Hyg 66(5):533\u2013541","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"135_CR8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","volume":"4","author":"M. Niedrig","year":"1999","unstructured":"Niedrig M, Lademann M, Emmerich P, Lafrenz M (1999) Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and Elisa. Trop Med Int Health 4(12):867\u2013871","journal-title":"Trop Med Int Health"},{"issue":"6","key":"135_CR9","first-page":"895","volume":"59","author":"J.D. Poland","year":"1981","unstructured":"Poland JD, Calisher CH, Monath TP et al (1981) Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine. Bull World Health Organ 59(6):895\u2013900","journal-title":"Bull World Health Organ"},{"issue":"4","key":"135_CR10","doi-asserted-by":"crossref","first-page":"e1993","DOI":"10.1371\/journal.pone.0001993","volume":"3","author":"A.H. Roukens","year":"2008","unstructured":"Roukens AH, Vossen AC, Bredenbeek PJ, et al (2008) Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled noninferiority trial. PloS One 3(4):e1993","journal-title":"PloS One"},{"issue":"18","key":"135_CR11","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.vaccine.2009.02.049","volume":"27","author":"A.H. Roukens","year":"2009","unstructured":"Roukens AH, Vossen AC, van Dissel JT, Visser LG (2009) Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy. Vaccine 27(18): 2408\u20132409. Epub 2009 Feb 24","journal-title":"Vaccine"},{"key":"135_CR12","volume-title":"\u00c9tude de la s\u00e9roprotection \u00e0 long terme de la vaccination contre la fi\u00e8vre jaune chez des sujets immunod\u00e9prim\u00e9s. Abstract CO-A 09","author":"P. Stumpf","year":"2007","unstructured":"Stumpf P, Van Der Vliet D, Simons De Fanti A, et al (2007) \u00c9tude de la s\u00e9roprotection \u00e0 long terme de la vaccination contre la fi\u00e8vre jaune chez des sujets immunod\u00e9prim\u00e9s. Abstract CO-A 09, 13es Actualit\u00e9s du Pharo, Marseille"},{"key":"135_CR13","volume-title":"Int\u00e9r\u00eat du titrage des anticorps antiamarils chez des sujets \u00e0 risque d\u00e9j\u00e0 vaccin\u00e9s contre la fi\u00e8vre jaune","author":"D. Vliet Van Der","year":"2006","unstructured":"Van Der Vliet D, Goujon C, Perignon A, et al (2006) Int\u00e9r\u00eat du titrage des anticorps antiamarils chez des sujets \u00e0 risque d\u00e9j\u00e0 vaccin\u00e9s contre la fi\u00e8vre jaune. Abstract D-12, 7es Journ\u00e9es nationales d\u2019infectiologie, Bordeaux"},{"issue":"5","key":"135_CR14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/597006","volume":"48","author":"O. Veit","year":"2009","unstructured":"Veit O, Niedrig M, Chapuis-Taillard C, et al (2009) Immunogenicity and safety of yellow fever vaccination for 102-HIV infected patients. Clin Infect Dis 48(5):659\u2013666","journal-title":"Clin Infect Dis"}],"container-title":["Bulletin de la Soci\u00e9t\u00e9 de pathologie exotique"],"original-title":[],"language":"fr","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13149-011-0135-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13149-011-0135-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13149-011-0135-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T13:11:57Z","timestamp":1559999517000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13149-011-0135-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,18]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["135"],"URL":"https:\/\/doi.org\/10.1007\/s13149-011-0135-7","relation":{},"ISSN":["0037-9085","1961-9049"],"issn-type":[{"value":"0037-9085","type":"print"},{"value":"1961-9049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,18]]}}}